Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

BackgroundIn Poland drug programmes developed by the Minister of Health and financed by the National Health Fund are special reimbursement frameworks of innovative, expensive, and mostly hospital based medical products used for a small number of patients.Research DesignThe research presented in this...

Full description

Bibliographic Details
Main Authors: Aneta Mela, Łukasz A. Poniatowski, Bartłomiej Drop, Marzena Furtak-Niczyporuk, Janusz Jaroszyński, Witold Wrona, Anna Staniszewska, Jan Dąbrowski, Anna Czajka, Beata Jagielska, Monika Wojciechowska, Maciej Niewada
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Pharmacology
Subjects:
drug programmes
public payer expenditures
reimbursement
cancer drugs
drug therapy
hospital medicinal products
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.01123/full

Similar Items

Similar Items